Veterinary Medicines

Zobuxa 50 mg Tablets for Cats and Dogs

Not authorised
  • Enrofloxacin
Download as PDF

Product identification

Medicine name:
Zobuxa 50 mg tablets for cats and dogs
Zobuxa 50 mg Tablets for Cats and Dogs
Active substance:
  • Enrofloxacin
Target species:
  • Dog
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Enrofloxacin
    50.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01MA90
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Expired
Authorised in:
  • United Kingdom (Northern Ireland)
Package description:
  • (ID1) 10 Tablet: unspecified outer container with 1 Blister (Aluminium) with 10 Tablet
  • (ID2) 100 Tablet: unspecified outer container with 1 Blister (Aluminium) with 100 Tablet

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Elanco Europe Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Elanco France S.A.S.
Responsible authority:
  • The Veterinary Medicines Directorate
Authorisation number:
  • Vm 00879/4025
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0197/002